A single annual injection against infection

This annual shot might protect against HIV infections
Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
Once-a-year shot for HIV protection passes early safety trial
An annual shot to protect against HIV infection has successfully passed an early safety trial, according to research published in The Lancet medical journal. The drug lenacapavir passed a critical Phase I testing trial and now may become a highly-effective and convenient form of HIV prevention.
New advance against HIV: a single annual injection against the infection
Data from a very early-phase trial shows that the drug is safe and remains in the body for up to 56 weeks. From two injections per year to one against HIV. "It is a hopeful step and the study data are positive.
Gilead data suggest once-yearly shot of PrEP drug blocks HIV infection
Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against infection with just a
HIV drug could offer yearlong protection with a single shot
A new formulation of Gilead's HIV prevention drug, lenacapavir, has shown promise in providing yearlong protection with just one injection. The study, published in The Lancet, evaluated the pharmacokinetics,
Revolutionary HIV injection could offer a full year of protection in just one dose
A groundbreaking annual injection designed to protect against Human Immunodeficiency Virus (HIV) has successfully
HIV's latent reservoir: New insights into Nef protein offer potential strategy to improve treatment
A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...
MIT Technology Review22h
The Download: HIV prevention shots, and fixing a broken sex doll
Every year, my colleagues and I put together a list of what we think are the top 10 breakthrough technologies of that year.
Medindia6h
HIV Cure Closer? Scientists Discovers New Way to Trace Dormant HIV Cells
A new method is developed to track dormant HIV-infected cells. This breakthrough may lead to new treatments that eliminate ...
Managed Healthcare Executive1d
If Twice-Yearly Lenacapavir Could Be a HIV PrEP Game Changer, Would a Once-Yearly Version Be a HIV Epidemic Ender?
Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...
BlackDoctor.org16h
HIV Rates Are Dropping—But Not for Everyone. Here’s Why.
HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.
The Montgomery Advertiser on MSN1d
Alabama still fighting HIV: 'In the South is where we have the majority of the problems':
Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...
Science Daily14h
Injectable Therapy is 'magic' for those who can't take HIV pills
Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.